CTIS2023-505726-34-02进行中（未招募）1 期
Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolism
Karolinska University Hospital0 个研究点目标入组 8 人开始时间: 2024年1月31日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- Male
入选标准
- •18-64 year old, Male
排除标准
- •Cardiovascular disease, Any chronic medication use, Steroid treatment for the last six months or HRT, Coagulopathy, Musculoskeletal or neurologic disease, Inclusion in any other concurrent medical research study, Cerebrovascular disease (e.g. stroke, prior aneurysm), Pulmonary disease (e.g. pulmonary hypertension, COPD), Metabolic disease (incl. but not limited to Cushing disease, Diabetes), Renal disease (by CKD criteria), Active inflammatory bowel syndrome, Cancer, Pregnancy, Smoker
研究者
相似试验
尚未招募
早期 1 期
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid MetabolismAcute Metabolic Effects of Evolocumab and AtorvastatinNCT06140095Region Stockholm8
尚未招募
2 期
PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSSColorectal CancerNCT06391905Guangdong Provincial People's Hospital60
招募中
不适用
Impact of PCSK9 Inhibitor on the Characteristics of Lipid-rich Coronary Plaques Assessed by Near-infrared SpectroscopyIschemic Heart DiseaseJPRN-UMIN000040318Gifu Heart Center50
Unknown
2 期
PCSK9 Inhibitors in the Progression of Aortic StenosisAortic Valve StenosisNCT03051360Seoul National University Hospital140
尚未招募
Unknown
The early administration of PCSK9 inhibitors in patients with acute ischemic stroke and its impact on the prognosis of stroke and changes in lipid profilesDiseases of the circulatory systemKCT0009238Asan Medical Center200